Zolpidem is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aci Healthcare Usa, Inc. The primary component is Zolpidem Tartrate.
Product ID | 71093-155_86e297bc-311b-4a0f-8cdd-d6f44d7e2bad |
NDC | 71093-155 |
Product Type | Human Prescription Drug |
Proprietary Name | Zolpidem |
Generic Name | Zolpidem Tartrate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2020-03-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA077214 |
Labeler Name | ACI Healthcare USA, Inc |
Substance Name | ZOLPIDEM TARTRATE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [CS],Central Nervous System Depression [PE] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-09-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA077214 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-03-01 |
Marketing Category | ANDA |
Application Number | ANDA077214 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-03-01 |
Ingredient | Strength |
---|---|
ZOLPIDEM TARTRATE | 5 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9962 | Zolpidem | Zolpidem |
0143-9963 | Zolpidem | Zolpidem |
71093-156 | Zolpidem | Zolpidem |
71093-155 | Zolpidem | Zolpidem |
63629-1170 | Zolpidem | Zolpidem |
63629-1171 | Zolpidem | Zolpidem |
0024-5401 | Ambien | zolpidem tartrate |
0024-5421 | Ambien | zolpidem tartrate |
0024-5501 | Ambien | zolpidem tartrate |
0024-5521 | Ambien | zolpidem tartrate |
0037-6010 | Edluar | Zolpidem Tartrate |
0037-6050 | Edluar | Zolpidem Tartrate |
0054-0086 | Zolpidem Tartrate | zolpidem tartrate |
0054-0087 | Zolpidem Tartrate | zolpidem tartrate |
0093-0073 | Zolpidem Tartrate | Zolpidem Tartrate |
0093-0074 | Zolpidem Tartrate | Zolpidem Tartrate |